Effects of agents which elevate cyclic AMP on guinea-pig eosinophil homotypic aggregation

British Journal of Pharmacology

Volumn 118, Issue 8, 1996, Pages 2099-2106

  Teixeira, M M ^a   Rossi, A G ^a,b   Giembycz, M A ^a   Hellewell, P G ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b Rayne Laboratory   (United Kingdom)

Author keywords

Aggregation; CD18; Cyclic AMP; Eosinophils; Phosphodiesterase inhibitors; Prostaglandins; 2 adrenoceptor agonists

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CD18 ANTIGEN; COMPLEMENT COMPONENT C5A; CYCLIC AMP; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHOSPHODIESTERASE INHIBITOR; PROSTAGLANDIN E1; PROTEIN KINASE INHIBITOR; ROLIPRAM; SALBUTAMOL; SALMETEROL; THROMBOCYTE ACTIVATING FACTOR;

ALLERGIC DISEASE; ANIMAL CELL; ARTICLE; CELL SURFACE; CONTROLLED STUDY; EOSINOPHIL; FEMALE; GUINEA PIG; INFLAMMATION; LEUKOCYTE AGGREGATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0029808036     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15649.x     Document Type: Article

References (43)

1. BAKER, A.J. & FULLER, R.W. (1990). Anti-inflammatory effect of salmeterol on human alveolar macrophages. Am. Rev. Respir. Dis., 141, A394.
2. 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo. Br. J. Pharmacol., 104, 665-671.
3. BARNETTE, M.S., MANNING, C.D., CIESLINSKI, L.B., BURMAN, M., CHRISTENSEN, S.B. & TORPHY, T.J. (1995). The ability of phosphodiesterase IV inhibitors to suppress Superoxide production in guinea pig eosinophils is correlated with inhibition of phosphodiesterase IV catalytic activity. J. Pharmacol. Exp. Ther., 273, 674-679.
4. BUTCHERS, F.R. & VARDEY, C.J. (1990). The effect of prostanoids on the function of human eosinophils. Agents Actions, 31(S), 103-112.
5. BUTTERFIELD, J.H. & LEIFERMAN, K.M. (1993). Eosinophil-associated diseases. In Immunopharmacology of Eosinophils. ed. Smith, H. & Cook, R.M. pp. 152-192. London: Academic Press.
6. CORRIGAN, C.J. & KAY, A.B. (1992). T cells and eosinophils in the pathogenesis of asthma. Immunology Today, 13, 501-507.
7. DAS, A.M., WILLIAMS, T.J., LOBB, R.R. & NOURSHARGH, S. (1995). Lung eosinophilia is dependent on IL-5, and the adhesion molecules CD18 and VLA-4 in a guinea-pig model. Immunology, 84, 41-46.
8. DENT, G., GIEMBYCZ, M.A., RABE, K.F. & BARNES, P.J. (1991). Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan-stimulated respiratory burst by 'type IV'-selective PDE inhibitors. Br. J. Pharmacol., 103, 1339-1346.
9. DENT, G., GIEMBYCZ, M.A., EVANS, P.M., RABE, K.F. & BARNES, P.J. (1995). Suppression of human eosinophil respiratory burst and cyclic AMP hydrolysis by inhibitors of type IV phosphodiesterase: interaction with the beta adrenoceptor agonist albuterol. J. Pharmacol. Exp. Ther., 271, 1167-1174.
10. DERIAN, C.K., SANTULLI, R.J., RAO, P.E., SOLOMON, H.F. & BARRETT, J.A. (1995). Inhibition of chemotactic peptide-induced neutrophil adhesion to vascular endothelium by cAMP modulators. J. Immunol., 154, 308-317.
11. DIAMOND, M.S. & SPRINGER, T.A. (1994). The dynamic regulation of integrin adhesiveness. Current Biology, 4, 506-517.
12. DJUKANOVIC, R., ROCHE, W.R., WILSON, J.W., BEASLEY. C.R.W., TWENTYMAN, O.P., HOWARTH, P.M. & HOLGATE, S.T. (1990). Mucosal inflammation in asthma. Am. Rev. Respir. Dis., 142, 434-457.
13. DUSTIN, M.L. & SPRINGER, T.A. (1989). T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature, 341, 619-624.
14. FUGNER, A. (1989). Formation of oedema and accumulation of eosinophils in the guinea pig lung. Inhibition by inhaled Beta-stimulants. Int. Archs. Allergy Appl. Immunol., 88, 225-227.
15. GIEMBYCZ, M.A. (1992). Could isoenzyme-selective phosphodiesterase inhibitors render bronchodilator therapy redundant in the treatment of bronchial asthma. Biochem. Pharmacol., 43, 2041-2051.
16. GIEMBYCZ, M.A. & KELLY, J.J. (1994). Current status of cyclic nucleotide phosphodiesterase isoenzymes. In Methylxanthines and Phosphodiesterase Inhibitors in the Treatment of Airways Disease, ed. Costello, J.F. & Piper, P.J. pp. 27-55. London: Parthenon Press.
17. GLEICH, G.J., ADOLPHSON, C.R. & LEIFERMAN, K.M. (1993). The biology of the eosinophilic leukocyte. Anna. Rev. Med., 44, 85-101.
18. HATZELMANN, A., TENOR, H. & SCHUDT, C. (1995). Differential effect of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions. Br. J. Pharmacol., 114, 821-831.
19. HOWELL, R.E., SICKELS, B.D. & WOEPPEL, S.L. (1993). Pulmonary antiallergic and bronchodilator effects of isoenzyme-selective phosphodiesterase inhibitors in guinea pigs. J. Pharmacol. Exp. Ther., 264, 609-615.
20. KITA, H., ABU-GHAZALEH, R.L, GLEICH, G.J. & ABRAHAM, R.T. (1991). Regulation of Ig-induced eosinophil degranulation by adenosine 3′,5′-cyclic monophosphate. J. Immunol., 146, 2712-2718.
21. KOENDERMAN, L., KUIJPERS, T.W., BLOM, M., TOOL, A.T.J., ROOS. D. & VERHOEVEN, A.J. (1991). Characteristics of CR3-mediated aggregation in human eosinophils: Effect of priming by platelet-activating factor. J. Allergy Clin. Immunol., 87, 947-954.
22. MCLAREN, D.J. (1980). Schistosoma Mansoni: The Parasite Surface in Relation to Host Immunity, Chichester, UK: Research Studies Press.
23. MEURER, R., VAN RIPER, G , FEENEY, W., CUNNINGHAM, P., HORA, D., SPRINGER, M.S., MACINTYRE, D.E. & ROSEN, H. (1993). Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattraetant protein 1, human macrophage inflammatory protein 1α, or human interleukin 8. J. Exp. Med., 178, 1913-1921.
24. MILNE, A.A.Y. & PIPER. P.J. (1994). The effects of two anti-CD8 antibodies on antigen-induced airway hyperresponsiveness and leukocyte accumulation in the guinea pig. Am. J. Respir. Cell Mol. Biol., 11, 337-343.
25. 4. J. Pharmacol. Exp. Ther., 268, 139-143.
26. MUNOZ, N.M., RABE, K.F., VITA, A.J., MCALLISTER, K., MAYER, D., WEIS, M. & LEFF, A.R. (1995). Paradoxical blockade of beta adrenergically mediated inhibition of stimulated eosinophil secretion by salmeterol. J. Pharmacol. Exp. Ther., 273, 850-854.
27. RABE, K.F., GIEMBYCZ, M.A., DENT, G., PERKINS, R.S., EVANS, P. & BARNES, P.J. (1993). Salmeterol is a competitive antagonist at β-adrenoceptors mediating inhibition of respiratory burst in guinea pig eosinophils. Eur. J. Pharmacol., 231, 305-308.
28. SOUNESS, J.E., CARTER, C.M., DIOCEE, B.K., HASSALL, G.A., WOOD, L.J. & TURNER, N.C. (1991). Characterization of guinea-pig eosinophil phosphodiesterase activity. Biochem. Pharmacol., 42, 937-945.
29. SOUNESS, J.E., MASLEN, C., WEBBER, S., FOSTER, M., RAEBURN, D., PALFREYMAN, M.N. & KARLSSON, J-A. (1995). Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP-specific phosphodiesterase: comparison with rolipram. Br. J. Pharmacol., 115, 39-46.
30. SOUNESS, J.E. & SCOTT, L.E. (1993). Stereospecificity of rolipram actions on eosinophil cyclic AMP phosphodiesterase. Biochem. J., 292, 389-395.
31. SOUNESS, J.E., VILLAMIL, M.E., SCOTT, L.S., TOMKINSON, A., GIEMBYCZ, M.A. & RAEBURN, D. (1994). Possible role of cyclic AMP phosphodiesterases in the actions of ibudilast on eosinophil tromboxane generation and airways smooth muscle tone. Br. J. Pharmacol., 111, 1081-1088.
32. TEIXEIRA, M.M., HELLEWELL, P.G. & ROSSI, A.G. (1996). Adhesion mechanisms involved in C5a-induced eosinophil homotypic aggregation. J. Leuk. Biol., 59, 389-396.
33. TEIXEIRA, M.M., TEYNIA, S., ROBINSON, M., SHOCK, A., WILLIAMS, T.J., WILLIAMS, F.M., ROSSI, A.G. & HELLEWELL, P.G. (1994a). Role of CD18 in the accumulation of eosinophils and neutrophils and local oedema formation in inflammatory reactions in guinea pig skin. Br. J. Pharmacol., 111, 811-818.
34. TEIXEIRA, M.M., ROSSI, A.G., WILLIAMS, T.J. & HELLEWELL, P.G. (1994b). Effects of phosphodiesterase isoenzyme inhibitors on cutaneous inflammation in the guinea-pig. Br. J. Pharmacol., 112, 332-340.
35. TEIXEIRA, M.M., WILLIAMS, T.J. & HELLEWELL, P.G. (1993). E-type prostaglandins enhance local oedema formation and neutrophil accumulation but suppress eosinophil accumulation in guinea pig skin. Br. J. Pharmacol., 110, 416-422.
36. TEIXEIRA, M.M., WILLIAMS, T.J., AU, B-T., HELLEWELL, P.G. & ROSSI, A.G. (1995a). Characterisation of eosinophil homotypic aggregation. J. Leuk. Biol., 57, 226-234.
37. 2-adrenoceptor agonist in guinea pig skin. Eur. J. Pharmacol., 272, 185-193.
38. TING, S., ZWEIMAN, B. & LAVKER, R. (1983). Terbutaline modulation of human allergic skin reaction. J. Allergy Clin. Immunol., 71, 437-441.
39. TORPHY, T.J. & UNDEM, B.J. (1991). Phosphodiesterase inhibitors: new opportunities for the treatment of asthma. Thorax, 46, 512-523.
40. UNDERWOOD, D.C., OSBORN, R.R., NOVAK, L.B., MATTHEWS J.K., NEWSHOLME, S.J., UNDEM, B.J., HAND, J.M. & TORPHY, T.J. (1993). Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram. J. Pharmacol. Exp. Ther., 266, 306-313.
41. UNDERWOOD, D.C., KOTZER, C.J., BOCHNOWICZ, S., OSBORN, R.R., LUTTMAN, M.A., HAY, D.W.P. & TORPHY, T.J. (1994). Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophilia influx in guinea pigs. J. Pharmacol. Exp. Ther., 270, 250-259.
42. WHELAN, C.J. & JOHNSON, M. (1992). Inhibition by salmeterol of increased vascular permeability and granulocyte accumulation in guinea-pig lung and skin. Br. J. Pharmacol., 105, 831-838.
43. ZECH-KAPP, G., KROEGEL, C., RIEDE, U.N. & KAPP, A. (1995). Mechanisms of human eosinophil activation by complement protein C5a and platelet-activating factor: similar functional responses are accompanied by different morphological alterations. Allergy, 50, 34-47.